ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
16
Funding Rounds
$328.8m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** La***** |
|
- |
| Name | Phone | Social networks | |
|---|---|---|---|
| Li** Po**** | - | - | - |
| Ia* F. Sm*** | - | - | - |
| Pa** J. Ha****** | - | - | - |
| Lu**** Ia******* | - | - | - |
| As*** K. Xa**** | - | - | - |
| Ad** Ko**** | - | - | - |
| Fr** Mi******* | - | - | - |
| Ma** G. Fo***** | - | - | - |
| Sa**** E. Po*** | - | - | - |
| Am** Za**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** La***** |
|
- |
The company ViaCyte has raised a total of $197m in funding over 16 rounds.